We are live on
!
Find out more
EAM
Erste Asset Management Portfolio holdings
AUM
$12.9B
1-Year Est. Return
52.69%
This Fund
S&P 500
This Quarter
Est. Return
+22.79%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$3.61B
AUM Growth
+$682M
(+23%)
Cap. Flow
+$151M
Cap. Flow
% of AUM
4.18%
Top 10 Holdings %
Top 10 Hldgs %
17.47%
Holding
529
New
83
Increased
179
Reduced
131
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$37.4M |
| 2 |
Signet Jewelers
SIG
|
+$12.4M |
| 3 |
Microsoft
MSFT
|
+$12.2M |
| 4 |
Walmart Inc
WMT
|
+$10.7M |
| 5 |
TJX Companies
TJX
|
+$9.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Darden Restaurants
DRI
|
+$28.9M |
| 2 |
Tapestry
TPR
|
+$12.7M |
| 3 |
Ameriprise Financial
AMP
|
+$11.9M |
| 4 |
Abbott
ABT
|
+$9.45M |
| 5 |
Denali Therapeutics
DNLI
|
+$6.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.66% |
| 2 | Healthcare | 21.76% |
| 3 | Consumer Discretionary | 15.04% |
| 4 | Industrials | 8.92% |
| 5 | Financials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YMAB
376
DELISTED
Y-mAbs Therapeutics
YMAB
| $504K | 0.01% |
+10,000
| New | +$463K |
|
377
Steel Dynamics
STLD
$34.3B
| $498K | 0.01% |
+13,700
| New | +$476K |
|
378
Veeva Systems
VEEV
$43.2B
| $496K | 0.01% |
1,800
| – | – |
|
379
Scholar Rock
SRRK
$6.09B
| $490K | 0.01% |
+10,300
| New | +$374K |
|
|
VIE
380
DELISTED
Viela Bio, Inc. Common Stock
VIE
| $487K | 0.01% |
+13,400
| New | +$469K |
|
381
Replimune Group
REPL
$1.23B
| $486K | 0.01% |
+11,900
| New | +$496K |
|
382
American Express
AXP
$219B
| $484K | 0.01% |
4,100
-2,255
| -35% | -$250K |
|
383
Freeport-McMoran
FCX
$99.6B
| $478K | 0.01% |
19,000
+14,400
| +313% | +$299K |
|
384
Genmab
GMAB
$21B
| $477K | 0.01% |
+12,000
| New | +$449K |
|
385
Pembina Pipeline
PBA
$27.5B
| $465K | 0.01% |
+19,400
| New | +$456K |
|
386
Nkarta
NKTX
$206M
| $462K | 0.01% |
+7,200
| New | +$299K |
|
387
Atara Biotherapeutics
ATRA
$94.8M
| $449K | 0.01% |
+880
| New | +$406K |
|
388
FMC
FMC
$1.41B
| $440K | 0.01% |
3,854
+2,052
| +114% | +$228K |
|
389
B2Gold
BTG
$6.9B
| $436K | 0.01% |
+76,629
| New | +$468K |
|
|
BKI
390
DELISTED
Black Knight, Inc. Common Stock
BKI
| $425K | 0.01% |
4,818
-9,843
| -67% | -$893K |
|
391
Ligand Pharmaceuticals
LGND
$5.52B
| $425K | 0.01% |
6,893
-4,649
| -40% | -$265K |
|
392
Keros Therapeutics
KROS
$221M
| $425K | 0.01% |
+5,700
| New | +$359K |
|
393
Aurinia Pharmaceuticals
AUPH
$2.15B
| $418K | 0.01% |
30,000
-61,000
| -67% | -$888K |
|
394
MacroGenics
MGNX
$257M
| $411K | 0.01% |
+18,000
| New | +$414K |
|
395
Brown & Brown
BRO
$22.5B
| $410K | 0.01% |
+8,900
| New | +$410K |
|
396
Pfizer
PFE
$157B
| $409K | 0.01% |
11,083
-101,441
| -90% | -$3.72M |
|
397
Ball Corp
BALL
$16.1B
| $406K | 0.01% |
+4,400
| New | +$407K |
|
398
Reinsurance Group of America
RGA
$16.2B
| $403K | 0.01% |
3,500
-2,000
| -36% | -$223K |
|
399
Vaxcyte
PCVX
$8.81B
| $398K | 0.01% |
+14,200
| New | +$528K |
|
|
TBIO
400
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $390K | 0.01% |
+20,000
| New | +$358K |
|
Similar funds
FFA
GKIM
WI
CRM
PCM
BCI
VLKIM
BAMF
Erste Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, Erste Asset Management held 529 positions worth $3.61B, up 23% from $2.93B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Erste Asset Management deployed $151M of net new capital in Q4 2020, opening 83 new positions and adding to 179 existing holdings. Its largest new stake was Signet Jewelers: 485,000 shares worth $13.5M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tapestry, an estimated $12.7M trimmed.
- Erste Asset Management's largest Q4 2020 buy was Signet Jewelers: 485,000 shares worth $13.5M.
- Erste Asset Management added most to Biogen in Q4 2020, an estimated $37.4M increase.
- Erste Asset Management's biggest Q4 2020 reduction was Tapestry, cutting an estimated $12.7M.
- Erste Asset Management fully exited Darden Restaurants in Q4 2020, selling an estimated $28.9M.
- Erste Asset Management's ten largest holdings make up 17% of its $3.61B portfolio in Q4 2020.
- Erste Asset Management opened 83 new positions and closed 34 in Q4 2020.
- Erste Asset Management's portfolio value rose 23% quarter-over-quarter to $3.61B.
Based on Erste Asset Management's 13F filing for Q4 2020, filed 25 Nov 2024.